Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

Clinical Rheumatology

Volumn 29, Issue 7, 2010, Pages 819-820

  Nagashima, Takao ^a   Minota, Seiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; ETANERCEPT; JO 1 ANTIBODY; TUMOR NECROSIS FACTOR INHIBITOR; IMMUNOGLOBULIN G; NONSTEROID ANTIINFLAMMATORY AGENT; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AUTOIMMUNE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; LETTER; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; CHEMICALLY INDUCED; COMPLICATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DERMATOMYOSITIS; HUMANS; IMMUNOGLOBULIN G; POLYMYOSITIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956262789     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1467-6     Document Type: Letter

References (10)

1. Ishikawa Y, Yukawa N, Ohmura K, Hosono Y, Imura Y, Kawabata D, Nojima T, Fujii T, Usui T, Mimori T (2010) Etanerceptinduced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Rheumatol 29:563-566
2. Martínez-Cordero E, León DE, Ortega LA (2001) Association of polymyositis with rheumatoid arthritis. Rheumatol Int 20:119-123
3. Nagashima T, Onishi S, Kamata Y, Minota S (2009) Dermatomyositis associated with thyroid cancer: a paraneoplastic syndrome? Rheumatol Int 29:1261-1262
4. Nagashima T, Iwamoto M, Minota S (2010) Antisynthetase syndrome associated with long-standing rheumatoid arthritis. Rheumatol Int. doi:10.1007/s00296-00010-01467-00295
5. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019-1038
6. Schmidt WA, Wetzel W, Friedländer R, Lange R, Sörensen HF, Lichey HJ, Genth E, Mierau R, Gromnica-Ihle E (2000) Clinical and serological aspects ofpatients with anti-Jo-1 antibodies-an evolving spectrum of disease manifestations. Clin Rheumatol 19:371-377
7. Comby E, Tanaff P, Mariotte D, Costentin-Pignol V, Marcelli C, Ballet JJ (2006) Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy. J Rheumatol 33:24-30
8. Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86:242-251
9. Kiltz U, Fendler C, Braun J (2008) Neuromuscular involvement in rheumatic patients treated with anti-tumor necrosis factor therapythree examples. J Rheumatol 35:2074-2076
10. Urata Y, Wakai Y, Kowatari K, Nitobe T, Mizushima Y (2006) Polymyositis associated with infliximab treatment for rheumatoid arthritis. Mod Rheumatol 16:410-411